Entera Bio ENTX
NASDAQ ENTX
$3.02 -0.03 (-0.98%)
At close: Oct 22, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Other financing activities (2024 - 2026)

Updated

Entera Bio (ENTX) recorded Other financing activities of $262,000 in FY2025, down 18.9% from $323,000 in FY2024.

Analysis

Entera Bio (ENTX) Other financing activities (2024 - 2026) Analysis & Trends

  • Per Business Quant data, ENTX's Other financing activities was $323,000 in FY2024 (-44.3%) and $580,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Entera Bio 151.86 Mn 120.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -171,000.00
Sep 30, 2025 -1,000.00
Jun 30, 2025 -75,000.00
Mar 31, 2025 -186,000.00
Dec 31, 2024 -304,000.00
Jun 30, 2024 -19,000.00
API Access

Entera Bio Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ENTX&period=max&api_key=YOUR_API_KEY